Company Presentation

InCephalo AG

Category:Emerging Biotech Company
Date:April 24, 2023
Speaker:Carlo Bertozzi, CEO

Company profile

InCephalo develops exclusively local treatments for neurological diseases, with a focus on cancers in the brain (primary brain cancers as well as secondary brain cancers). The proprietary Compartment Lock technology, also called C-Lock, retains biologics, that are applied locally behind the blood brain barrier, in the central nervous system (CNS) and once they leave the CNS, degrades them rapidly in the systemic compartment.

Follow us